Victory Capital Management Inc Ionis Pharmaceuticals Inc Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 18,350 shares of IONS stock, worth $691,428. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,350

Previous 17,330 5.89%

Holding current value

$691,428

Previous $825,000 10.91%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$40.06 - $51.86 $40,861 - $52,897	1,020 Added 5.89%	18,350 $735,000
Q2 2024 Aug 05, 2024	SELL	$36.45 - $47.7 $11,190 - $14,643	-307 Reduced 1.74%	17,330 $825,000
Q1 2024 May 03, 2024	SELL	$42.03 - $53.55 $426,856 - $543,853	-10,156 Reduced 36.54%	17,637 $764,000
Q4 2023 Feb 05, 2024	BUY	$43.39 - $51.63 $536,170 - $637,991	12,357 Added 80.05%	27,793 $1.41 Million
Q3 2023 Nov 06, 2023	BUY	$38.5 - $47.13 $13,398 - $16,401	348 Added 2.31%	15,436 $700,000
Q2 2023 Jul 27, 2023	SELL	$34.73 - $43.33 $12,190 - $15,208	-351 Reduced 2.27%	15,088 $619,000
Q1 2023 May 02, 2023	SELL	$33.58 - $41.2 $11,685 - $14,337	-348 Reduced 2.2%	15,439 $551,000
Q4 2022 Feb 10, 2023	BUY	$37.12 - $46.52 $5,271 - $6,605	142 Added 0.91%	15,787 $596,000
Q4 2022 Feb 09, 2023	SELL	$37.12 - $46.52 $5,568 - $6,978	-150 Reduced 0.95%	15,645 $590,000
Q3 2022 Nov 02, 2022	BUY	$36.54 - $48.66 $82,178 - $109,436	2,249 Added 16.6%	15,795 $699,000
Q2 2022 Aug 01, 2022	BUY	$31.71 - $43.0 $54,572 - $74,003	1,721 Added 14.55%	13,546 $501,000
Q1 2022 May 04, 2022	SELL	$29.88 - $37.04 $39,501 - $48,966	-1,322 Reduced 10.06%	11,825 $435,000
Q4 2021 Feb 07, 2022	SELL	$25.61 - $35.1 $4,917 - $6,739	-192 Reduced 1.44%	13,147 $400,000
Q3 2021 Nov 02, 2021	SELL	$33.54 - $40.55 $29,414 - $35,562	-877 Reduced 6.17%	13,339 $447,000
Q2 2021 Aug 03, 2021	SELL	$34.54 - $47.25 $415,654 - $568,606	-12,034 Reduced 45.84%	14,216 $567,000
Q1 2021 May 04, 2021	SELL	$42.51 - $63.78 $2.51 Million - $3.77 Million	-59,040 Reduced 69.22%	26,250 $1.18 Million
Q4 2020 Feb 01, 2021	BUY	$45.3 - $60.27 $523,350 - $696,299	11,553 Added 15.67%	85,290 $4.82 Million
Q3 2020 Nov 09, 2020	BUY	$47.45 - $62.95 $2.69 Million - $3.57 Million	56,637 Added 331.21%	73,737 $3.5 Million
Q2 2020 Aug 07, 2020	SELL	$46.85 - $61.05 $29,843 - $38,888	-637 Reduced 3.59%	17,100 $1.01 Million
Q1 2020 May 04, 2020	BUY	$41.6 - $63.4 $77,625 - $118,304	1,866 Added 11.76%	17,737 $839,000
Q4 2019 Feb 06, 2020	SELL	$53.85 - $65.27 $17,770 - $21,539	-330 Reduced 2.04%	15,871 $959,000
Q4 2019 Feb 04, 2020	SELL	$53.85 - $65.27 $12,008 - $14,555	-223 Reduced 1.36%	16,201 $945,000
Q3 2019 Nov 12, 2019	BUY	$59.06 - $72.15 $970,001 - $1.18 Million	16,424 New	16,424 $984,000
Q3 2017 Oct 27, 2017	SELL	$45.56 - $59.57 $26,925 - $35,205	-591 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	591	591 $30,000

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Ionis Pharmaceuticals Inc Transaction History